|
WO2020131923A1
|
|
Automatic standardization pipeline for data analysis
|
|
WO2019090353A1
|
|
Control processes for microorganism-related characterization processes
|
|
CN111201324A
|
|
Single molecule sequencing and unique molecular identifiers to characterize nucleic acid sequences
|
|
CN111164224A
|
|
Index of importance related to microorganism
|
|
US2019019575A1
|
|
Nasal-related characterization associated with the nose microbiome
|
|
US2019078142A1
|
|
Method and system for characterization for female reproductive system-related conditions associated with microorganisms
|
|
WO2019018580A1
|
|
Method and system for characterization for appendix-related conditions associated with microorganisms
|
|
US2018342322A1
|
|
Method and system for characterization for appendix-related conditions associated with microorganisms
|
|
US2018286520A1
|
|
Method and system for characterizing microorganism-associated sleep-related conditions
|
|
US2018122511A1
|
|
Method and system for characterizing microorganism-related conditions
|
|
US2018122510A1
|
|
Method and system for characterizing diet-related conditions
|
|
US2018114592A1
|
|
Method and system for characterizing allergy-related conditions associated with microorganisms
|
|
US2018102187A1
|
|
Method and system for characterizing a headache-related condition
|
|
WO2018094376A1
|
|
Method and system for characterizing a headache-related condition
|
|
US2018137240A1
|
|
Method and system for fragment assembly and sequence identification
|
|
EP3519593A1
|
|
Method and system for crispr-based library preparation and sequencing
|
|
US2018137239A1
|
|
Method and system for panel characterizations
|
|
CN109715059A
|
|
For a group method and system for characterization
|
|
CA3030792A1
|
|
Method and system for microbial pharmacogenomics
|
|
WO2017189614A1
|
|
Method and system for characterizing skin related conditions
|
